Last reviewed · How we verify
NCT06079658
The Effects of Continuous vs. Intermittent Caloric Restriction on Fat Los
NA trial testing Continuous Caloric Restriction versus Intermittent Caloric Restriction on Fat Loss in Obesity in 40 participants. Completed in 15 August 2023.
15 August 2023
Quick facts
| Lead sponsor | Coastal Carolina University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | single group |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 1 October 2022 |
| Primary completion | 15 August 2023 |
| Estimated completion | 15 August 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Continuous Caloric Restriction versus Intermittent Caloric Restriction on Fat Loss
Conditions studied
- Obesity — all drugs for Obesity →
Sponsor
Coastal Carolina University
Who can join
Adults 18 to 65, female only, with Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this research study examines fat mass loss using a continuous calorie reduction protocol versus continuous caloric restriction interspersed with "diet refeeds" and "diet breaks" over 12 weeks.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06079658
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Obesity
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
- NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting
Other Coastal Carolina University trials
Trials by the same sponsor.
- NCT06525337 — Adherence to Health Coaching with Wearable Devices: Enhancing Patient Engagement and Outcomes · NA · active not recruiting
- NCT04201028 — A Remote Delivered Lifestyle Therapeutics Program · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06079658 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Coastal Carolina University
- Last refreshed: 12 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06079658.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing